[email protected]

国际中医药研究

International Research in Chinese Medicine

您当前位置:首页 > 精选文章

International Research in Chinese Medicine. 2023; 3: (2) ; 10.12208/j.ircm.20230008 .

Effect of Wumen RMK-03TM active components on injury in LPS-treated nasal mucosa epithelial cells
吴门RMK-03TM喷剂有效组分对脂多糖引起的鼻黏膜上皮细胞损伤的作用研究

作者: 梁国强, 冒华, 江国荣 *

南京中医药大学附属苏州市中医医院 江苏苏州

苏州有生医疗科技有限公司 江苏苏州

*通讯作者: 江国荣,单位:南京中医药大学附属苏州市中医医院 江苏苏州;

引用本文: 梁国强, 冒华, 江国荣 吴门RMK-03TM喷剂有效组分对脂多糖引起的鼻黏膜上皮细胞损伤的作用研究[J]. 国际中医药研究, 2023; 3: (2) : 15-20.
Published: 2023/4/26 15:49:34

摘要

目的 研究吴门RMK-03TM喷剂有效组分对脂多糖(LPS)处理的鼻黏膜上皮细胞增殖和细胞炎性因子表达的影响。方法 体外培养人鼻黏膜上皮细胞HNEpC,用 0、1、2、4、8、16mg/L的RMK-03TM喷剂有效组分处理24h或48h,采用 CCK8法检测细胞增殖活性。将细胞分为空白对照组(不处理)、LPS 组(100 mg/L LPS 处理24h)和LPS + RMK-03TM喷剂有效组分组(100mg/L LPS 处理24h后加入4mg/L或8mg/L RMK-03TM喷剂有效组分作用24 h),采用CCK8法检测细胞增殖活性,ELISA法检测细胞中IL-1和TNF-α的表达,Western blot法检测细胞中蛋白p-IκBα、p-P65和血管紧张素转化酶2(ACE2)蛋白的表达。结果 RMK-03TM喷剂有效组分可促进鼻黏膜上皮细胞增殖,4-16mg/L 虫草素对鼻黏膜上皮细胞的增殖促进作用最明显。与空白对照组相比,LPS 组细胞增殖活性下降,IL-1β、TNF-α分泌含量和 p-IκBα、p-P65和ACE2蛋白的表达升高(P<0.01);与LPS 组相比,LPS + RMK-03TM喷剂有效组分组细胞增殖活性升高,IL-1β、TNF-α分泌含量和 p-IκBα、p-P65、ACE2蛋白的表达降低(P<0.01)。结论 吴门RMK-03TM喷剂有效组分可以促进鼻黏膜上皮细胞增殖和抑制细胞炎症因子分泌,可能与抑制p-IκBα、p-P65和ACE2蛋白的表达有关。

关键词: 吴门RMK-03TM喷剂;HNEpC上皮细胞;脂多糖;细胞损伤

Abstract

Objective To study the effect of Wumen RMK-03TM active components on the cell proliferation and expression of cytokines in LPS-induced nasal mucosa epithelial cells.
Methods HNEpC cells were cultured in vitro and the effect of Wumen RMK-03TM active components at different doses (0, 1, 2, 4, 8, 16mg/L) on the proliferation of human nasal mucosa epithelial cells was detected by CCK8 method. The cells were divided into four groups, blank control group (not treated), LPS group (treated with 100mg/L LPS for 24 hours), and LPS + RMK-03TM active components groups (4mg/L or 8mg/L components for 24hours after being treated with 100mg/L LPS for 24 hours). The proliferation of nasal mucosa epithelial cells was detected by CCK8 method. The contents of IL-1β and TNF-α a in the cell supernatant were detected by ELISA method. The expressions of p-IκBα, p-P65 and ACE2 proteins were detected by Western blot.
Results The proliferation activity of nasal mucosa epithelial cells increased after RMK-03TM active components treatment, especially the RMK-03TM active components at 416mg/L. Compared with the blank control group, the proliferation activity of LPS group was decreased, the contents of IL-1β, TNF-α and p-IκBα, p-P65, ACE2 protein were increased significantly (P<0.05). Compared with LPS group, the proliferation activity of LPS + RMK-03TM active components groups was increased, the contents of IL-1β, TNF-α and p-IκBα, p-P65, ACE2 proteins were decreased (P<0.05).
Conclusion   Wumen RMK-03TM active components can promote the proliferation of LPS induced nasal mucosa epithelial cells and inhibit the secretion of inflammatory cytokines. The possible mechanism is that RMK-03TM active components can inhibit the expression of the p-IκBα, p-P65 and ACE2 proteins.

Key words: Wumen RMK-03TM; HNEpC epithelial cells; LPS; cell injury

参考文献 References

[1] Chen Z, Liu J, Chen J, et al. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;34(11):1053-1056.

[2] 刘霞,张小刚,郭新艳等.玻璃酸二甲基硅烷醇复合物对鼻黏膜上皮细胞的作用研究[J].食品与药品,2020,22(03):204-207.

[3] Li Y, Sun L, Zhang Y. Programmed cell death in the epithelial cells of the nasal mucosa in allergic rhinitis. Int Immunopharmacol. 2022;112:109252.

[4] Bergougnoux A, Claustres M, De Sario A. Nasal epithelial cells: a tool to study DNA methylation in airway diseases. Epigenomics. 2015;7(1):119-126.

[5] 冒华,吴晓松,石根勇等.瑞美科皮肤黏膜抗菌护理喷剂杀菌性能的实验研究[J].江苏卫生保健,2011,13(03):1-3.

[6] 陆富永,明海霞,尹仲等.瑞美科皮肤粘膜抗菌护理喷剂对尖锐湿疣电灼术后创面的影响[J].中国现代医药杂志,2011,13(12):91-92.

[7] 冒昊天,江国荣,梁国强等.RMK-03TM皮肤黏膜护理喷剂对上呼吸道黏膜免疫功能低下小鼠免疫调节机制的影响[J].抗感染药学,2021,18(12):1738-1744.

[8] 姚香萍,彭红星,吴金如.虫草素对脂多糖处理的鼻黏膜上皮细胞增殖和细胞因子表达的影响[J].郑州大学学报(医学版),2020,55(06):858-861.

[9] 周迎, 熊婷, 陈莹, 李海刚 染料木素抗PC12神经细胞炎症作用实验研究[J]. 国际中医药研究, 2022; 2: (4): 26-28.

[10] 彭林峰,冯家茹,王明刚等.补气通窍方调控Treg/Th17平衡缓解变应性鼻炎大鼠鼻黏膜炎性损伤的机制[J].中华中医药杂志,2022,37(03):1648-1651.

[11] Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8.

[12] Ning Z, Pawitan Y, Shen X. High-definition likelihood inference of genetic correlations across human complex traits. Nature Genetics. 2020; 52:859–864.

[13] Brevini T, Maes M, Webb GJ, et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature. 2023;615(7950):134-142.

[14] Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119-128.